Aurobindo Pharma Limited has informed the Exchange about Schedule of meet
AUROPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aurobindo Pharma has informed the exchanges that its officials will participate in the 'Ashwamedh – Elara India Dialogue 2025' investor meeting on September 4, 2025, from 9:00 AM to 6:00 PM IST in Mumbai. The meeting will include in-person and group interactions with investors. The company clarified that no unpublished price-sensitive information (UPSI) will be discussed during the interactions. The schedule is subject to change based on circumstances on either side.
This is a routine disclosure about investor engagement with no material business or financial information shared. No direct impact on stock price or shareholders is expected from this announcement alone.